Nothing Special   »   [go: up one dir, main page]

Park et al., 1989 - Google Patents

Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane

Park et al., 1989

View HTML
Document ID
18094782662749838295
Author
Park S
Harker L
Marzec U
Levin E
Publication year

External Links

Snippet

Fibrinolytic activity was found to be associated with sonicated platelet membranes after separation from cytosol by differential centrifugation. This fibrinolytic activity was attributed to the presence of a plasminogen activator, which was immunochemically identified as urinary …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Park et al. Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane
Hoffman et al. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation
Schapira et al. Purified human plasma kallikrein aggregates human blood neutrophils.
Colucci et al. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
Ogston The physiology of hemostasis
Wilson et al. Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.
Niléhn et al. Demonstration of fibrinolytic split products in human serum by an immunological method in spontaneous and induced fibrinolytic states
Åberg et al. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII
JP2008289498A (en) Purified multimerase
Clark et al. Effects of recombinant erythropoietin on murine megakaryocytic colony formation in vitro
Switalska et al. A method radioimmunoassay of human platelet thrombospondin: Different patterns of thrombospondin and β-thromboglobulin antigen secretion and clearance from the circulation
Speiser et al. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veins
Strauss et al. Characterization and properties of an inhibitor of factor VIII in the plasma of patients with hemophilia A following repeated transfusions
Kane et al. Activation of coagulation factor V by a platelet protease
Nachman et al. Immunological studies of proteins associated with the subcellular fractions of thrombasthenic and afibrinogenaemic platelets
Drake et al. Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells
Carvalho et al. Intravascular coagulation in hyperlipidemia
Heilmann et al. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins.
Petrequin et al. Expression of specific granule markers on the cell surface of neutrophil cytoplasts
Molino et al. Effects of leukocyte-derived cathepsin G on platelet membrane glycoprotein Ib-IX and IIb-IIIa complexes: a comparison with thrombin
Lo et al. Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium.
Bode et al. Plasmin activity and complement activation during storage of citrated platelet concentrates
Levine Secreted platelet proteins as markers for pathological disorders
Nakashima et al. Thrombin enhances production and release of tissue plasminogen activator from bovine venous endothelial cells
Bray et al. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders